- Home
- Industry Reports
- Healthcare
- Pharmaceuticals
- Global Plasma Fractionation Market – Size, Outlook, Trends and Forecast (2023 – 2030)
Plasma fractionation refers to the general processes of separating various components of blood plasma. The global plasma fractionation market will be growing at a CAGR of 6.83% to reach $34.28 Billion by 2025, from $XX Billion in 2019 during 2019-2025. The key attributes responsible for the growth of the global plasma fractionation market are growing used of immunoglobulins in various therapeutic areas, rising geriatric population across the globe, increase in plasma collection and growing prevalence of respiratory diseases. High cost, limited reimbursement and the emergence of recombinant alternatives are obstructing the growth of the global plasma fractionation market. Growing number of patients with haemophilia are creating significant opportunities for the market growth.
Research Study Objectives:
- Define, estimate, and forecast the plasma fractionation market statistics by product, application, end user and regions concerning the individual growth drivers, market trends and their contribution toward the plasma fractionation market growth
- Provides comprehensive information regarding the key factors influencing the market growth (Drivers, Restraints & Challenges, and Opportunities)
- Estimate & forecast the market size of all the segments concerning geographies including North America, Europe, Asia Pacific (APAC), South America and the Middle East and Africa (MEA).
- Recent competitive developments including M&A (Mergers and Acquisitions), Partnerships, and Product Innovations are provided in the plasma fractionation market analysis
- Analysis and conclusions on the future plasma fractionation market outlook.
Top-down and bottom-up approaches are used to validate the plasma fractionation market size and are used to estimate the size of other dependent submarkets. Key players in the market are identified through various secondary sources; databases including Bloomberg Businessweek, Hoovers, Factiva, journals and associations and the market revenues are estimated and are thoroughly validated through primary and secondary research. Secondary research involves the study of annual and financial reports of top players in the market, whereas primary research includes extensive interviews with the KoL’s such as CEOs, directors, board members, VP’s, sales managers, engineers, marketing executives, technicians, account managers, investors, strategic decision makers and others. The plasma fractionation market shares and breakdowns are determined using secondary sources and are verified by the primary sources. All possible parameters/factors that are affecting the plasma fractionation market demand are covered in the research study are verified through primary research, analysed and interpreted to get the final qualitative and quantitative data. This data is collected and added with detailed analysis from Envision Inteligence and presented in this report.
The scope of the Report
The plasma fractionation market segmentation is as follows:
BY PRODUCT
- Immunoglobulin
- Coagulation Factor Concentrates
- Albumin
- Protease Inhibitors
- Other Plasma Products
BY APPLICATION
- Neurology
- Immunology
- Haematology
- Critical care
- Pulmonology
- Hemato-Oncology
- Rheumatology
BY END USER
- Hospital &clinics
- Clinical research laboratories
- Research institutes
Geographical Analysis:
Plasma Fractionation Market is segmented by geography into North America, South America, Europe, APAC and Middle East & Africa. U.S., Canada, Mexico and Costa Rica are analysed under North American region which is usually turning as the hotspot in the market. The South American region is further segregated into Brazil, Argentina, Chile, Columbia and some other emerging economies. In Europe, the market is extensively examined by covering U.K., Germany, France, Italy, Spain, Netherlands, Poland, Switzerland and some other promising economies. APAC is further categorised by countries into China, India, Japan, South Korea, Australia & New Zealand, Malaysia, Singapore and many other emerging nations. In the Middle East & African region, Saudi Arabia, UAE, Iran, Iraq, Qatar, South Africa, Algeria, Morocco, Nigeria and so on countries are evaluated to understand the market growth lucidly.
Customization Options:
With the given research report, Envision Inteligence offers customisations as per the client’s specific requirements. The following customisation options offered for the plasma fractionation market include:
- Scope Revision
- Geographic Analysis
- Company Profiles
- Historical Data & Forecasting
- Key Contact Persons in companies
Global Plasma Fractionation Market Research Report Includes:
- An executive summary condensing the whole report such that essential authority can rapidly twist up doubtlessly acquainted with brief overview and conclusion.
- To have a complete market analysis through industry value chain analysis, Porter’s Five Force Model, PESTLE, SWOTanalysis, and Y-o-Y analysis.
- Regional and global diversity is analysed with the major countries and the unions. Scrutinizing the revenue generation on year–on–year
- Identifying DROC in the current market and their impact on altering market dynamics.
- Competitive landscape analysis to identify the merger and acquisition which will have a comparative financial study with significant competitors.
- Expertise investment opportunities by an analyst to the individual and organisation to have a better foothold in the market.
- Identify the latest developments, market shares and strategies that are employed by the significant plasma fractionation market players, such as
- China Biologic Products, Inc.
- Bio Products Laboratory
- Green Cross Corporation
- Japan Blood Products Organization
- Bharat Serums and Vaccines
- Along with these companies, many other companies are considered in the report while analysing the global plasma fractionation competitive strategies and environment. These companies held substantial share-owning to the nature of the industry whereas, the rest of the market shares are marginal chunks to regional and local level manufacturers. Other players also have considerable presence owing to its robust brand image, geographical reach and stable customer base.
CHAPTER 1. INTRODUCTION
1.1. Market Definition
1.2. Executive Summary
1.3. The Scope of the Study
CHAPTER 2. RESEARCH METHODOLOGY
2.1. Secondary Research
2.2. Primary Research
2.3. Analytic Tools and Model
2.4. Economic Indicator
2.4.1 Base Year, Base Currency, Forecasting Period
2.5. Expert Validation
2.6. Study Timeline
CHAPTER 3. MARKET ANALYSIS
3.1. Industry Value Chain Analysis
3.2. Porter’s Five Force Analysis
3.2.1. Bargaining Power of Buyers
3.2.2. Bargaining Power of Suppliers
3.2.3. Threats of Substitutes
3.2.4. Threats of New Entrants
3.2.5. Degree of Competition
3.3. PESTLE Analysis
3.3.1. Political
3.3.2. Economical
3.3.3. Social
3.3.4. Technological
3.3.5. Legal
3.3.6. Environmental
3.4. SWOT Analysis
3.4.1. Strengths
3.4.2. Weakness
3.4.3. Opportunities
3.4.4. Threats
3.5. Y-O-Y Analysis
CHAPTER 4. MARKET DYNAMICS
4.1. Market Drivers
4.1.1. The rise in the plasma collection
4.1.2. Growing geriatric population across the globe
4.1.3. Increase in the prevalence of respiratory diseases
4.1.4. Growing use of immunoglobulins in various therapeutic areas
4.2. Market Restraints & Challenges
4.2.1. The emergence of recombinant alternatives
4.2.2. High cost and limited reimbursement
4.2.3. Stringent government regulations
4.3. Market Opportunities
4.3.1. Growing number of patients with haemophilia
CHAPTER 5. GLOBAL PLASMA FRACTIONATION MARKET – BY PRODUCT
5.1. Introduction
5.2. Immunoglobulin
5.2.1 Intravenous Immunoglobulin (IVIG)
5.2.2 Subcutaneous Immunoglobulin (SCIG)
5.2.3 Other Immunoglobulins
5.3 Coagulation Factor Concentrates
5.3.1 Factor VIII
5.3.2 Factor IX
5.3.3 Von Willebrand Factor
5.3.4 Prothrombin Complex Concentrate
5.3.5 Fibrinogen Concentrates
5.3.6 Factor XIII
5.4 Albumin
5.5 Protease Inhibitors
5.6 Other Plasma Products
CHAPTER 6. GLOBAL PLASMA FRACTIONATION MARKET – BY APPLICATION
6.1. Neurology
6.2. Haematology
6.3. Immunology
6.4. Critical care
6.5. Hemato-Oncology
6.6. Pulmonology
6.7. Rheumatology
6.8. Others
CHAPTER 7. GLOBAL PLASMA FRACTIONATION MARKET – BY END USER
7.1. Hospital &clinics
7.2. Clinical research laboratories
7.3. Research institutes
CHAPTER 8. GLOBAL PLASMA FRACTIONATION MARKET – BY GEOGRAPHY
8.1. Introduction
8.2. North America
8.2.1. U.S.
8.2.2. Canada
8.2.3. Mexico
8.2.4. Costa Rica
8.3. South America
8.3.1. Brazil
8.3.2. Argentina
8.3.3. Chile
8.3.4. Columbia
8.3.5. Others
8.4. Europe
8.4.1. U.K.
8.4.2. Germany
8.4.3. France
8.4.4. Italy
8.4.5. Spain
8.4.6. Russia
8.4.7. Netherlands
8.4.8. Switzerland
8.4.9. Poland
8.4.10. Others
8.5. APAC
8.5.1. China
8.5.2. Japan
8.5.3. India
8.5.4. South Korea
8.5.5. Australia & New Zealand
8.5.6. Malaysia
8.5.7. Singapore
8.5.8. Others
8.6. Middle East & Africa
8.6.1. UAE
8.6.2. Saudi Arabia
8.6.3. Iran
8.6.4. Iraq
8.6.5. Qatar
8.6.6. South Africa
8.6.7. Algeria
8.6.8. Morocco
8.6.9. Nigeria
8.6.10. Egypt
8.6.11. Others
CHAPTER 9. GLOBAL PLASMA FRACTIONATION MARKET – COMPANY
PROFILES
9.1. China Biologic Products, Inc.
9.2. CSL Limited
9.3. Octapharma AG
9.4. Shire Plc.
9.5. Kedrion Biopharma
9.6. LFB S.A.
9.7. Sanquin
9.8. Grifols, S.A.
9.9. Japan blood Products Organization
9.10. Green Cross Corporation
9.11. Bio Products Laboratory
9.12. Shanghai Raas Blood Products Co., Ltd
9.13. Biotest AG
9.14. Beijing Tiantan Biological Products Corp
9.15. Bharat Serums and Vaccines Limited
CHAPTER 10. GLOBAL PLASMA FRACTIONATION MARKET – COMPETITIVE
LANDSCAPE
10.1. Market Share Analysis
10.2. Strategies adopted by top companies
10.3. Mergers, Acquisitions, Collaborations & Agreements
CHAPTER 11. MARKET INSIGHTS
11.1. Industry Experts Insights
11.2. Analysts Opinions
11.3. Investment Opportunities
CHAPTER 12. APPENDIX
12.1. List of Tables
12.2. List of Figures
- Competitive Analysis in marketing and strategic management is an assessment of the strengths and weaknesses of current and potential competitors.
- Monitoring the external and internal factors which affect the market dynamics with the aid of PESTLE analysis.
- The Regional and Global Variety is taken care of in the report.
- Year on Year basis generation of revenue is studied.
- Porter's Five Forces analyze the intensity of competition in an industry and its profitability level.
- The overview and the sustainability of the market are analyzed through SWOT.
- DROC (Drivers, Restraints, Opportunities and Challenges) is recognized in the current market scenario and see how its effect on market dynamics.
- The segment-level analysis in terms of type and technology.
- The value chain analysis, value that's created and captured by a company is the profit margin.
- Value Created and Captured – Cost of Creating that Value = Margin
- An executive summary consists of the whole report and the outcome is been given in the report to have brief knowledge about the report.
- Basis on the depth of the study we approach using analytical tools
- Expertise investment opportunities are given after analyzing the market to give the organization and the individual to have perfect knowledge about the market.
Global Report
$2,700.00 – $8,100.00
- EUR: €2,511.39 - €7,534.18
- INR: ₹223,024.12 - ₹669,072.36
- AED: د.إ9,909.00 - د.إ29,727.00
- GBP: £2,180.22 - £6,540.65
Additional information
Report Type | Extensive Report, Miniature report, Snapshot Report |
---|---|
Licence | Single User License, Team License, Corporate License |
Plasma fractionation refers to the general processes of separating various components of blood plasma. The global plasma fractionation market will be growing at a CAGR of 6.83% to reach $34.28 Billion by 2025, from $XX Billion in 2019 during 2019-2025. The key attributes responsible for the growth of the global plasma fractionation market are growing used of immunoglobulins in various therapeutic areas, rising geriatric population across the globe, increase in plasma collection and growing prevalence of respiratory diseases. High cost, limited reimbursement and the emergence of recombinant alternatives are obstructing the growth of the global plasma fractionation market. Growing number of patients with haemophilia are creating significant opportunities for the market growth.
Research Study Objectives:
- Define, estimate, and forecast the plasma fractionation market statistics by product, application, end user and regions concerning the individual growth drivers, market trends and their contribution toward the plasma fractionation market growth
- Provides comprehensive information regarding the key factors influencing the market growth (Drivers, Restraints & Challenges, and Opportunities)
- Estimate & forecast the market size of all the segments concerning geographies including North America, Europe, Asia Pacific (APAC), South America and the Middle East and Africa (MEA).
- Recent competitive developments including M&A (Mergers and Acquisitions), Partnerships, and Product Innovations are provided in the plasma fractionation market analysis
- Analysis and conclusions on the future plasma fractionation market outlook.
Top-down and bottom-up approaches are used to validate the plasma fractionation market size and are used to estimate the size of other dependent submarkets. Key players in the market are identified through various secondary sources; databases including Bloomberg Businessweek, Hoovers, Factiva, journals and associations and the market revenues are estimated and are thoroughly validated through primary and secondary research. Secondary research involves the study of annual and financial reports of top players in the market, whereas primary research includes extensive interviews with the KoL’s such as CEOs, directors, board members, VP’s, sales managers, engineers, marketing executives, technicians, account managers, investors, strategic decision makers and others. The plasma fractionation market shares and breakdowns are determined using secondary sources and are verified by the primary sources. All possible parameters/factors that are affecting the plasma fractionation market demand are covered in the research study are verified through primary research, analysed and interpreted to get the final qualitative and quantitative data. This data is collected and added with detailed analysis from Envision Inteligence and presented in this report.
The scope of the Report
The plasma fractionation market segmentation is as follows:
BY PRODUCT
- Immunoglobulin
- Coagulation Factor Concentrates
- Albumin
- Protease Inhibitors
- Other Plasma Products
BY APPLICATION
- Neurology
- Immunology
- Haematology
- Critical care
- Pulmonology
- Hemato-Oncology
- Rheumatology
BY END USER
- Hospital &clinics
- Clinical research laboratories
- Research institutes
Geographical Analysis:
Plasma Fractionation Market is segmented by geography into North America, South America, Europe, APAC and Middle East & Africa. U.S., Canada, Mexico and Costa Rica are analysed under North American region which is usually turning as the hotspot in the market. The South American region is further segregated into Brazil, Argentina, Chile, Columbia and some other emerging economies. In Europe, the market is extensively examined by covering U.K., Germany, France, Italy, Spain, Netherlands, Poland, Switzerland and some other promising economies. APAC is further categorised by countries into China, India, Japan, South Korea, Australia & New Zealand, Malaysia, Singapore and many other emerging nations. In the Middle East & African region, Saudi Arabia, UAE, Iran, Iraq, Qatar, South Africa, Algeria, Morocco, Nigeria and so on countries are evaluated to understand the market growth lucidly.
Customization Options:
With the given research report, Envision Inteligence offers customisations as per the client’s specific requirements. The following customisation options offered for the plasma fractionation market include:
- Scope Revision
- Geographic Analysis
- Company Profiles
- Historical Data & Forecasting
- Key Contact Persons in companies
Global Plasma Fractionation Market Research Report Includes:
- An executive summary condensing the whole report such that essential authority can rapidly twist up doubtlessly acquainted with brief overview and conclusion.
- To have a complete market analysis through industry value chain analysis, Porter’s Five Force Model, PESTLE, SWOTanalysis, and Y-o-Y analysis.
- Regional and global diversity is analysed with the major countries and the unions. Scrutinizing the revenue generation on year–on–year
- Identifying DROC in the current market and their impact on altering market dynamics.
- Competitive landscape analysis to identify the merger and acquisition which will have a comparative financial study with significant competitors.
- Expertise investment opportunities by an analyst to the individual and organisation to have a better foothold in the market.
- Identify the latest developments, market shares and strategies that are employed by the significant plasma fractionation market players, such as
- China Biologic Products, Inc.
- Bio Products Laboratory
- Green Cross Corporation
- Japan Blood Products Organization
- Bharat Serums and Vaccines
- Along with these companies, many other companies are considered in the report while analysing the global plasma fractionation competitive strategies and environment. These companies held substantial share-owning to the nature of the industry whereas, the rest of the market shares are marginal chunks to regional and local level manufacturers. Other players also have considerable presence owing to its robust brand image, geographical reach and stable customer base.
CHAPTER 1. INTRODUCTION
1.1. Market Definition
1.2. Executive Summary
1.3. The Scope of the Study
CHAPTER 2. RESEARCH METHODOLOGY
2.1. Secondary Research
2.2. Primary Research
2.3. Analytic Tools and Model
2.4. Economic Indicator
2.4.1 Base Year, Base Currency, Forecasting Period
2.5. Expert Validation
2.6. Study Timeline
CHAPTER 3. MARKET ANALYSIS
3.1. Industry Value Chain Analysis
3.2. Porter’s Five Force Analysis
3.2.1. Bargaining Power of Buyers
3.2.2. Bargaining Power of Suppliers
3.2.3. Threats of Substitutes
3.2.4. Threats of New Entrants
3.2.5. Degree of Competition
3.3. PESTLE Analysis
3.3.1. Political
3.3.2. Economical
3.3.3. Social
3.3.4. Technological
3.3.5. Legal
3.3.6. Environmental
3.4. SWOT Analysis
3.4.1. Strengths
3.4.2. Weakness
3.4.3. Opportunities
3.4.4. Threats
3.5. Y-O-Y Analysis
CHAPTER 4. MARKET DYNAMICS
4.1. Market Drivers
4.1.1. The rise in the plasma collection
4.1.2. Growing geriatric population across the globe
4.1.3. Increase in the prevalence of respiratory diseases
4.1.4. Growing use of immunoglobulins in various therapeutic areas
4.2. Market Restraints & Challenges
4.2.1. The emergence of recombinant alternatives
4.2.2. High cost and limited reimbursement
4.2.3. Stringent government regulations
4.3. Market Opportunities
4.3.1. Growing number of patients with haemophilia
CHAPTER 5. GLOBAL PLASMA FRACTIONATION MARKET – BY PRODUCT
5.1. Introduction
5.2. Immunoglobulin
5.2.1 Intravenous Immunoglobulin (IVIG)
5.2.2 Subcutaneous Immunoglobulin (SCIG)
5.2.3 Other Immunoglobulins
5.3 Coagulation Factor Concentrates
5.3.1 Factor VIII
5.3.2 Factor IX
5.3.3 Von Willebrand Factor
5.3.4 Prothrombin Complex Concentrate
5.3.5 Fibrinogen Concentrates
5.3.6 Factor XIII
5.4 Albumin
5.5 Protease Inhibitors
5.6 Other Plasma Products
CHAPTER 6. GLOBAL PLASMA FRACTIONATION MARKET – BY APPLICATION
6.1. Neurology
6.2. Haematology
6.3. Immunology
6.4. Critical care
6.5. Hemato-Oncology
6.6. Pulmonology
6.7. Rheumatology
6.8. Others
CHAPTER 7. GLOBAL PLASMA FRACTIONATION MARKET – BY END USER
7.1. Hospital &clinics
7.2. Clinical research laboratories
7.3. Research institutes
CHAPTER 8. GLOBAL PLASMA FRACTIONATION MARKET – BY GEOGRAPHY
8.1. Introduction
8.2. North America
8.2.1. U.S.
8.2.2. Canada
8.2.3. Mexico
8.2.4. Costa Rica
8.3. South America
8.3.1. Brazil
8.3.2. Argentina
8.3.3. Chile
8.3.4. Columbia
8.3.5. Others
8.4. Europe
8.4.1. U.K.
8.4.2. Germany
8.4.3. France
8.4.4. Italy
8.4.5. Spain
8.4.6. Russia
8.4.7. Netherlands
8.4.8. Switzerland
8.4.9. Poland
8.4.10. Others
8.5. APAC
8.5.1. China
8.5.2. Japan
8.5.3. India
8.5.4. South Korea
8.5.5. Australia & New Zealand
8.5.6. Malaysia
8.5.7. Singapore
8.5.8. Others
8.6. Middle East & Africa
8.6.1. UAE
8.6.2. Saudi Arabia
8.6.3. Iran
8.6.4. Iraq
8.6.5. Qatar
8.6.6. South Africa
8.6.7. Algeria
8.6.8. Morocco
8.6.9. Nigeria
8.6.10. Egypt
8.6.11. Others
CHAPTER 9. GLOBAL PLASMA FRACTIONATION MARKET – COMPANY
PROFILES
9.1. China Biologic Products, Inc.
9.2. CSL Limited
9.3. Octapharma AG
9.4. Shire Plc.
9.5. Kedrion Biopharma
9.6. LFB S.A.
9.7. Sanquin
9.8. Grifols, S.A.
9.9. Japan blood Products Organization
9.10. Green Cross Corporation
9.11. Bio Products Laboratory
9.12. Shanghai Raas Blood Products Co., Ltd
9.13. Biotest AG
9.14. Beijing Tiantan Biological Products Corp
9.15. Bharat Serums and Vaccines Limited
CHAPTER 10. GLOBAL PLASMA FRACTIONATION MARKET – COMPETITIVE
LANDSCAPE
10.1. Market Share Analysis
10.2. Strategies adopted by top companies
10.3. Mergers, Acquisitions, Collaborations & Agreements
CHAPTER 11. MARKET INSIGHTS
11.1. Industry Experts Insights
11.2. Analysts Opinions
11.3. Investment Opportunities
CHAPTER 12. APPENDIX
12.1. List of Tables
12.2. List of Figures
- Competitive Analysis in marketing and strategic management is an assessment of the strengths and weaknesses of current and potential competitors.
- Monitoring the external and internal factors which affect the market dynamics with the aid of PESTLE analysis.
- The Regional and Global Variety is taken care of in the report.
- Year on Year basis generation of revenue is studied.
- Porter's Five Forces analyze the intensity of competition in an industry and its profitability level.
- The overview and the sustainability of the market are analyzed through SWOT.
- DROC (Drivers, Restraints, Opportunities and Challenges) is recognized in the current market scenario and see how its effect on market dynamics.
- The segment-level analysis in terms of type and technology.
- The value chain analysis, value that's created and captured by a company is the profit margin.
- Value Created and Captured – Cost of Creating that Value = Margin
- An executive summary consists of the whole report and the outcome is been given in the report to have brief knowledge about the report.
- Basis on the depth of the study we approach using analytical tools
- Expertise investment opportunities are given after analyzing the market to give the organization and the individual to have perfect knowledge about the market.
Our Clientele
Exclusive Benefits
Credibility and Transparency
We actively recruit consumers, business professionals, and hard-to-reach individuals as members of our research panels, and we build trusted, ongoing relationships with them. Thus we provide the complete list of primary and secondary data sources in the report to maintain the transparency and to assure the credibility.
Exhaustive Coverage
Detailed and extensive coverage in the geography.Survey consultation for brand tracking, concept testing, consumer behaviour, and more, we have you covered with market research services that scale to meet your needs.
Competitive Edge
Our reports cover most recent updates in the market till the date of the purchase. We identify, gather and timely deliver analysis on impact of unprecedented decisions of CXOs in COVID-19 catastrophe on many businesses, their clients and their clients' clients without additional cost.
Golden Opportunities
A comprehensive strategic sieve analysis of the market by our analysts and consultants, aided by AI tools helps us find the non-obvious, golden and emerging opportunities for you to evaluate.
Top-notch Reports Guaranteed
70% of our research is exclusive; no other research firm has the depth and breadth of our research.
Post Purchase Support
Post-purchase support is provided for all our reports, for three months from the date of purchase, where related queries will be answered within 24 business hours over telephone or email.